Mirae Asset Global Investments’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$21.7K Buy
2025
Q1
$19.6K Buy
2024
Q4
$13.8K Buy
2024
Q3
$19.2K Buy
2024
Q2
$15.2K Sell
2024
Q1
$78.7K Buy
2023
Q4
$126K Buy
2022
Q4
Sell
2022
Q3
$145K Buy